Odd L. Gammelgaard

Odense, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoires.

Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoires.

Journal: Frontiers in immunology

Published: February 28, 2026

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial.

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial.

Journal: Journal for immunotherapy of cancer

Published: November 13, 2025

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 03, 2024

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: February 02, 2024

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Journal: Molecular cancer

Published: June 01, 2023

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer.

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer.

Journal: Cancers

Published: November 27, 2022

DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1.

DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1.

Journal: Cancer letters

Published: August 09, 2022

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.

Journal: Journal for immunotherapy of cancer

Published: July 28, 2022

SSX addiction in melanoma propagates tumor growth and metastasis.

SSX addiction in melanoma propagates tumor growth and metastasis.

Journal: Frontiers in oncology

Published: July 19, 2022

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

Journal: Nature communications

Published: September 17, 2021

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.

Journal: Molecular oncology

Published: January 09, 2021

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

Journal: Nature communications

Published: February 19, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026